Trial | NCT02576340  Report issue

Title

Spasmolytic in Upper Gastrointestinal Endoscopy
Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    400
Upper gastrointestinal system endoscopy is widely used for diagnostic approach. To increase the tolerability and compliance of the patient, sedation is applied. There are many studies showing that sedation increases the patient compliance and the tolerability. However, spasmolytic use in GE has not been evaluated yet.
Study Started
Jan 31
2013
Primary Completion
May 31
2013
Study Completion
Jun 30
2013
Last Update
Oct 15
2015
Estimate

Drug otilonium bromide

otilonium bromide was administered before the procedure

study Active Comparator

drug was administered

control No Intervention

no drug administered

Criteria 

Inclusion Criteria:

no hypersensitivity to the agent.

Exclusion Criteria:

Emergent cases,the cases with low mental compatibility and pregnant women were excluded from the study. Moreover, the procedures under sedation, cases with disorders decreasing the intestinal motility like hypothyroidism and diabetes were excluded.
No Results Posted